InnoCan Pharma Corporation
INNPF
$0.132
-$0.0031-2.30%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.06M | 5.19M | 4.60M | 3.89M | 4.02M |
| Total Receivables | 722.00K | 433.00K | 922.00K | 694.00K | 475.00K |
| Inventory | 3.43M | 2.66M | 2.60M | 1.75M | 1.68M |
| Prepaid Expenses | 187.00K | 206.00K | 656.00K | 340.00K | 406.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 85.00K | 105.00K | 137.00K | 138.00K | 144.00K |
| Total Current Assets | 9.48M | 8.59M | 8.91M | 6.80M | 6.73M |
|
|
|||||
| Total Current Assets | 9.48M | 8.59M | 8.91M | 6.80M | 6.73M |
| Net Property, Plant & Equipment | 118.00K | 122.00K | 128.00K | 136.00K | 134.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.60M | 8.72M | 9.04M | 6.94M | 6.87M |
|
|
|||||
| Total Accounts Payable | 132.00K | 389.00K | 477.00K | 112.00K | 333.00K |
| Total Accrued Expenses | -- | -- | -- | 463.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 22.00K | -- |
| Total Finance Division Other Current Liabilities | 2.52M | 2.28M | 3.85M | 1.95M | 2.02M |
| Total Other Current Liabilities | 2.52M | 2.28M | 3.85M | 1.95M | 2.02M |
| Total Current Liabilities | 2.65M | 2.67M | 4.33M | 2.54M | 2.35M |
|
|
|||||
| Total Current Liabilities | 2.65M | 2.67M | 4.33M | 2.54M | 2.35M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.00K | 4.00K | 7.00K | 11.00K | 16.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.65M | 2.68M | 4.33M | 2.55M | 2.37M |
|
|
|||||
| Common Stock & APIC | 39.95M | 39.33M | 38.95M | 37.18M | 36.49M |
| Retained Earnings | -34.79M | -34.50M | -34.84M | -33.07M | -32.19M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.15M | 4.83M | 4.11M | 4.10M | 4.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.15M | 4.83M | 4.11M | 4.10M | 4.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 1.79M | 1.22M | 596.00K | 283.00K | 196.00K |
| Total Equity | 6.94M | 6.04M | 4.71M | 4.39M | 4.50M |
|
|
|||||
